Medically reviewed content. Last updated: April 2026.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting hyperbaric oxygen therapy (HBOT). Individual eligibility depends on your specific medical history and current health status. Affiliate Disclosure: HBOT Finder may earn a commission from products linked in this article at no extra cost to you. This helps support our free resources.
Quick Answer: Good candidates for hyperbaric oxygen therapy include patients with non-healing diabetic wounds, radiation injuries, carbon monoxide poisoning, decompression sickness, chronic infections, and select neurological conditions. The FDA has cleared HBOT for 14 specific indications, and Medicare covers most of them. However, candidacy also depends on your ability to equalize ear pressure, tolerate enclosed spaces, and the absence of certain contraindications like untreated pneumothorax. A pre-treatment evaluation with a hyperbaric medicine physician is the first step to determining your eligibility.
What Hyperbaric Oxygen Therapy Actually Does (And Why Candidacy Matters)
Hyperbaric oxygen therapy places you inside a pressurized chamber — typically at 1.5 to 3.0 atmospheres absolute (ATA) — where you breathe 100% pure oxygen. At sea level, your blood carries oxygen almost exclusively via hemoglobin in red blood cells. Under pressure, oxygen dissolves directly into plasma, cerebrospinal fluid, and tissue fluid at concentrations 10 to 15 times higher than normal. That's not a marginal bump. It's a fundamental shift in how your body delivers oxygen to damaged tissue.
Why does this matter for candidacy? Because HBOT works through specific biological mechanisms — angiogenesis (new blood vessel formation), stem cell mobilization, reduction of inflammation, and enhanced white blood cell function. These mechanisms are therapeutically relevant only when your underlying condition involves tissue hypoxia, ischemia, infection, or inflammation that oxygen can address. A healthy person with no tissue damage won't see dramatic benefits. Someone with a diabetic foot ulcer that's been stagnant for months? The oxygen-starved tissue around that wound is exactly where HBOT excels.
The Undersea and Hyperbaric Medical Society (UHMS) maintains the gold-standard list of approved indications, currently at 14 conditions. The FDA has cleared hyperbaric chambers for these same uses. Medicare's National Coverage Determination (NCD 20.29) covers most of them, though with specific clinical criteria you need to meet.
According to the UHMS, approximately 2.4 million HBOT treatments are administered annually in the United States, with wound care accounting for roughly 70% of clinical sessions. That number has grown steadily — the global hyperbaric oxygen therapy market was valued at $3.8 billion in 2024 and is projected to reach $5.7 billion by 2030, reflecting both expanded clinical use and growing off-label interest.
But here's the thing most articles won't tell you: being diagnosed with an approved condition doesn't automatically make you a good candidate. Your overall health, medications, lung function, and even psychological comfort with enclosed spaces all factor into the decision. A thorough pre-treatment screening is what separates safe, effective therapy from wasted time and money.
For a broader overview of how the therapy works, see our HBOT Complete Guide [2026].
FDA-Cleared and UHMS-Approved Conditions: The Core Eligibility List
The strongest candidates for HBOT have one of the 14 conditions recognized by both the FDA and the UHMS. These aren't speculative uses — they're backed by decades of clinical evidence, controlled trials, and insurance coverage in most cases.
1. Air or Gas Embolism Gas bubbles enter the bloodstream during surgery, diving accidents, or central line placement. HBOT compresses the bubbles and forces them back into solution. This is emergency treatment — candidacy is immediate and unambiguous.
2. Carbon Monoxide Poisoning CO binds to hemoglobin with 200 to 250 times the affinity of oxygen. HBOT at 2.5 to 3.0 ATA reduces the half-life of carboxyhemoglobin from approximately 5 hours on room air to 20 to 30 minutes. Patients with CO levels above 25% (or above 15% in pregnant women), loss of consciousness, or neurological symptoms are strong candidates.
3. Clostridial Myositis and Myonecrosis (Gas Gangrene) Clostridial bacteria thrive in anaerobic environments. HBOT directly inhibits bacterial growth by flooding tissue with oxygen while enhancing antibiotic penetration. Surgical debridement remains primary treatment, but HBOT as adjunctive therapy significantly reduces mortality.
4. Crush Injuries, Compartment Syndrome, and Acute Traumatic Ischemias When tissue is crushed, blood flow is compromised and swelling worsens ischemia. HBOT reduces edema, preserves marginally viable tissue, and enhances the boundary between salvageable and nonsalvageable tissue. The key eligibility factor: treatment should begin within 4 to 6 hours of injury for best outcomes.
5. Decompression Sickness (DCS) The classic HBOT indication. Divers who ascend too quickly develop nitrogen bubbles in blood and tissue. HBOT is the definitive treatment — U.S. Navy Treatment Table 6 at 2.8 ATA is the standard protocol. Any diver with symptoms of DCS is an immediate candidate.
6. Arterial Insufficiency (Central Retinal Artery Occlusion) Added to the UHMS list in recent years, this "eye stroke" causes sudden vision loss. HBOT within 24 hours of onset can restore blood flow and preserve vision. Timing is everything — patients presenting beyond 24 hours see diminishing returns.
7. Severe Anemia (Exceptional Blood Loss) When transfusion is impossible — religious objection, rare blood type, antibody complications — HBOT delivers oxygen directly through plasma. Candidates typically have hemoglobin below 7 g/dL with acute symptoms.
8. Intracranial Abscess Brain abscesses treated with surgical drainage and antibiotics benefit from adjunctive HBOT, which enhances oxygen-dependent white blood cell killing of bacteria in abscess walls.
9. Necrotizing Soft Tissue Infections Flesh-eating bacterial infections like necrotizing fasciitis carry mortality rates of 25 to 35%. HBOT as an adjunct to aggressive surgical debridement and IV antibiotics improves tissue oxygenation in the infection margins.
10. Chronic Refractory Osteomyelitis Bone infections that fail to respond to 6 or more weeks of IV antibiotics and surgical debridement. HBOT enhances osteoclast activity (which removes dead bone) and white blood cell killing at the infection site. Studies show resolution rates of 60 to 85% when HBOT is added to standard care.
11. Delayed Radiation Injury (Soft Tissue and Bony Necrosis) Radiation damages the microvasculature, creating tissue that's chronically hypoxic — sometimes years after cancer treatment. HBOT stimulates angiogenesis in irradiated tissue. The landmark Marx protocol demonstrated that pre- and post-operative HBOT reduces osteoradionecrosis of the jaw from 30% to under 5%. Candidates include anyone with radiation-induced tissue damage, particularly in the head, neck, pelvis, or chest wall.
12. Compromised Skin Grafts and Flaps When a surgical graft or flap shows signs of compromised blood supply, HBOT can improve oxygen delivery to the graft margins and increase survival rates.
13. Thermal Burns Severe burns with deep partial-thickness or full-thickness injury. HBOT reduces edema, maintains viable tissue in the zone of stasis, and speeds healing when started within 24 hours.
14. Diabetic Wounds of the Lower Extremities This is the single largest category of HBOT patients. Medicare specifically requires: Wagner grade III or higher wound, failed an adequate course of standard wound therapy (at least 30 days), and no measurable improvement without intervention. According to CMS data, HBOT achieves complete healing in approximately 50 to 60% of qualifying diabetic wounds that failed standard care alone.
If you're dealing with any of these conditions, the next step is a consultation at a qualified center. Facilities like Penn Medicine and UI Health offer comprehensive pre-treatment evaluations for all UHMS-approved indications.
Off-Label Uses: Promising But Different Eligibility Standards
Beyond the 14 approved indications, HBOT is increasingly used for conditions where clinical evidence is growing but not yet at the level that triggers insurance coverage. If your condition falls here, you may still be a good candidate — but the evaluation process, cost structure, and expectations differ.
Traumatic Brain Injury (TBI) and Post-Concussion Syndrome Multiple randomized controlled trials — including the landmark Israeli study published in PLOS ONE — have shown measurable improvements in cognitive function, SPECT brain imaging, and quality of life in TBI patients treated with 40 to 60 sessions at 1.5 to 2.0 ATA. A 2024 meta-analysis across 12 trials found statistically significant improvements in cognitive scores and symptom severity. Good candidates typically have persistent post-concussive symptoms lasting 6 months or more that haven't responded to conventional rehabilitation.
Long COVID The Sagol Center randomized controlled trial (published in Scientific Reports, 2022) demonstrated significant improvements in cognitive function, psychiatric symptoms, and fatigue in long COVID patients after 40 sessions. Research continued through 2025 with multiple centers reporting consistent findings. Candidates for this off-label use typically present with persistent cognitive fog, fatigue, or exercise intolerance lasting 3 or more months after COVID-19 infection.
Stroke Recovery HBOT applied months to years after stroke has shown ability to activate neuroplasticity in penumbral (stunned but viable) brain tissue. The Tel Aviv University studies demonstrated meaningful functional improvements even years post-stroke. Good candidates have measurable neurological deficits and imaging evidence of viable penumbral tissue.
Anti-Aging and Longevity The widely reported 2020 Tel Aviv study showed HBOT lengthened telomeres by 20% and reduced senescent cells by 37% in healthy adults over age 64. While fascinating, this remains investigational. Candidates pursuing this use should be in good general health with no contraindications.
Autism Spectrum Disorder Some clinical trials have shown behavioral improvements in children with ASD following HBOT at mild pressures (1.3 to 1.5 ATA). Results are mixed, and no major medical society currently recommends this as standard treatment. Families pursuing this route should work with a physician experienced in both ASD and hyperbaric medicine.
The critical distinction: for off-label uses, you're almost certainly paying out of pocket. Sessions typically run $150 to $400 each, and protocols involve 20 to 60 sessions. That's $3,000 to $24,000 in total treatment costs. Make sure the evidence supports your specific situation before committing. Our HBOT Side Effects [2026] guide covers what to watch for during extended treatment courses.
Who Should NOT Get HBOT: Absolute and Relative Contraindications
Knowing who isn't a good candidate is just as important as knowing who is. Contraindications fall into two categories: absolute (never proceed) and relative (proceed with caution and modifications).
Absolute Contraindications
Untreated Pneumothorax A collapsed lung under pressure is life-threatening. The trapped air expands during decompression and can cause a tension pneumothorax — a medical emergency. Any patient with known or suspected pneumothorax must have it resolved before entering a chamber. No exceptions.
Certain Chemotherapy Agents Bleomycin (used in some lymphoma and testicular cancer protocols) causes pulmonary toxicity that HBOT can worsen dramatically. Patients who have ever received bleomycin are generally excluded. Cisplatin and doxorubicin also interact poorly with hyperbaric oxygen. If you've had cancer treatment, your full chemotherapy history must be reviewed before clearance.
Disulfiram (Antabuse) This medication, used for alcohol dependency, blocks superoxide dismutase — an enzyme that protects cells from oxygen toxicity. Patients on disulfiram face dramatically increased risk of oxygen seizures during HBOT.
Relative Contraindications
Upper Respiratory Infections or Chronic Sinusitis Congestion prevents equalization of pressure in the middle ear and sinuses. This doesn't permanently exclude you, but treatment should be delayed until the infection resolves. Decongestants or myringotomy tubes can sometimes allow treatment to continue.
Claustrophobia Monoplace chambers require lying inside a clear acrylic tube for 90 to 120 minutes. For patients with significant claustrophobia, this can be intolerable. Solutions include: sedation (mild anxiolytics), multiplace chambers where you sit in an open room with other patients, or gradual desensitization sessions. Facilities like MD Hyperbaric Chicago offer multiplace chambers that many claustrophobic patients find more tolerable.
Seizure Disorders Oxygen toxicity can trigger seizures, particularly at pressures above 2.0 ATA. Patients with epilepsy or low seizure thresholds aren't automatically excluded but require careful pressure selection, shorter treatment durations, and close monitoring. Anti-seizure medication dosing may need adjustment.
Pregnancy Historically listed as an absolute contraindication, the evidence is more nuanced. HBOT is clearly indicated for pregnant women with carbon monoxide poisoning (CO crosses the placenta and poisons the fetus). For elective indications, most providers defer treatment until after delivery due to limited safety data.
Implanted Devices Pacemakers, cochlear implants, and certain other devices may be affected by pressure changes. Modern devices are generally rated for hyperbaric pressures, but verification with the device manufacturer is required before treatment.
Congestive Heart Failure (NYHA Class IV) Severe heart failure patients may not tolerate the fluid shifts caused by hyperbaric pressure. Ejection fraction below 35% typically requires cardiology clearance before proceeding.
Chronic Obstructive Pulmonary Disease (COPD) Patients with air trapping (bullae or blebs) face risk of pulmonary barotrauma. Pre-treatment chest imaging is standard for COPD patients. Mild to moderate COPD is usually manageable; severe emphysema with large bullae may be disqualifying.
Understanding these risks is essential. Read more in our HBOT Side Effects [2026] article.
The Pre-Treatment Evaluation: What to Expect
You don't walk into a hyperbaric center and start treatment the same day. A proper pre-treatment evaluation is both a medical necessity and a quality indicator — if a facility skips this step, find another one.
Medical History Review
Your hyperbaric physician will review your complete medical history with specific attention to:
- Lung disease history: Asthma, COPD, previous pneumothorax, lung surgery. A chest X-ray is standard; CT scan if there's any concern about blebs or bullae.
- Ear, nose, and throat issues: History of ear surgery, tympanic membrane perforation, chronic sinusitis, or inability to equalize (Valsalva maneuver). You'll be tested on your ability to equalize during the evaluation.
- Cancer history: Full chemotherapy regimen review, particularly screening for bleomycin, cisplatin, and doxorubicin exposure.
- Medication list: Beyond disulfiram, your provider will screen for mafenide acetate (topical burn cream that can cause CO2 retention under pressure), certain ophthalmic drops, and sulfonylureas (which may increase hypoglycemia risk under pressure in diabetic patients).
- Cardiac history: Ejection fraction, presence of implanted devices, history of congestive heart failure.
- Psychological assessment: Claustrophobia screening, anxiety disorders, ability to communicate during treatment.
Physical Examination
A focused physical exam includes:
- Ear examination: Otoscopic exam to check for tympanic membrane pathology, wax impaction, or middle ear effusion.
- Pulmonary assessment: Lung auscultation, spirometry if COPD is suspected. Some centers perform baseline pulmonary function tests for patients undergoing extended treatment courses (20+ sessions).
- Neurological baseline: Particularly important for TBI, stroke, or DCS patients — establishing a documented neurological baseline allows objective measurement of improvement.
- Wound assessment: For diabetic wound patients, this includes measurement, photography, Wagner grading, vascular assessment (ABI, TcPO2), and documentation of prior failed treatments.
Transcutaneous Oxygen Measurement (TcPO2)
For wound patients, this test is particularly important. TcPO2 measures oxygen levels at the skin surface near the wound. A baseline TcPO2 below 40 mmHg suggests tissue hypoxia. More critically, a challenge test measures TcPO2 while breathing 100% oxygen — if levels rise above 200 mmHg, it predicts a favorable response to HBOT. Studies show that a positive TcPO2 challenge correlates with healing rates above 75%, while a negative challenge (no significant rise) predicts treatment failure in most cases.
Insurance Pre-Authorization
For approved indications, your provider will typically handle pre-authorization. Medicare requires documentation of: the specific approved diagnosis, failure of standard therapy (for wound patients, at least 30 days of documented standard wound care), and a treatment plan with defined endpoints. According to CMS guidelines, continued treatment beyond 30 days requires documented measurable signs of healing — if no progress is seen, coverage stops.
First-time patients can learn more about what to expect in our HBOT for Beginners guide.
Special Populations: Candidacy Considerations by Group
Different patient populations face unique eligibility considerations. What works for a 35-year-old athlete recovering from a concussion is a different calculation than a 72-year-old diabetic with peripheral vascular disease.
Elderly Patients (65+)
Older adults are actually among the most common HBOT patients, primarily for diabetic wounds and radiation injuries. Age alone is not a contraindication. However, several age-related factors affect candidacy:
- Ear equalization: Age-related Eustachian tube dysfunction is common. Roughly 15 to 20% of elderly patients struggle with equalization. Solutions include prophylactic myringotomy tubes, which are minor procedures that dramatically improve tolerance.
- Cardiac reserve: Patients with reduced ejection fraction need cardiology clearance. The hemodynamic effects of hyperbaric pressure are generally mild, but in borderline cardiac patients, even mild fluid shifts matter.
- Cognitive function: Patients with dementia may not be able to communicate discomfort, equalize on command, or remain calm in the chamber. This is a practical (not medical) limitation that affects safety.
- Polypharmacy: Elderly patients on multiple medications require careful drug interaction screening. Insulin-dependent diabetics need blood glucose monitoring before and after sessions, as HBOT can lower blood sugar.
Pediatric Patients
Children are treated with HBOT for carbon monoxide poisoning, thermal burns, necrotizing infections, and — in some specialized centers — cerebral palsy and autism (both off-label). Specific considerations include: See the cerebral palsy evidence atlas for the full investigational evidence breakdown.
- Ear equalization: Young children can't perform Valsalva on command. Myringotomy tubes are more commonly placed prophylactically in pediatric HBOT patients.
- Chamber tolerance: Children under 7 often need a parent in the chamber (multiplace setup) or mild sedation. Monoplace treatment in very young children requires specialized pediatric chambers.
- Oxygen toxicity: Children appear to have slightly different oxygen toxicity thresholds than adults. Treatment pressures are typically kept at 1.5 to 2.0 ATA for most pediatric protocols.
Athletes and Performance Recovery
Professional athletes increasingly pursue HBOT for sports injury recovery — ligament tears, fractures, concussions, and general recovery optimization. Several NFL, NBA, and Premier League teams maintain private chambers. For athletes, candidacy is straightforward: no contraindications, documented injury, and realistic expectations. HBOT isn't magic for recovery — it accelerates healing by perhaps 30 to 40% in controlled studies, not overnight. See celebrity endorsements vs. the actual recovery evidence for the endorsement-by-endorsement evidence audit.
Cancer Survivors
This is a nuanced group. Many cancer survivors are excellent HBOT candidates — specifically for delayed radiation injuries that develop months or years after treatment. The concern is whether HBOT promotes cancer growth. The evidence is reassuring: a 2012 systematic review in BMC Cancer analyzed 19 studies and found no evidence that HBOT stimulates cancer growth or recurrence. The UHMS position statement affirms that HBOT is not contraindicated in patients with a history of malignancy, provided they are not receiving concurrent bleomycin.
Patients with Anxiety or Mental Health Conditions
Claustrophobia is the most common psychological barrier. Beyond that, patients with PTSD, generalized anxiety disorder, or panic disorder may struggle with the enclosed environment, pressurization sensations, or the inability to leave the chamber mid-treatment. Strategies include:
- Pre-treatment facility tours and practice sessions
- Anxiolytic medication (benzodiazepines) taken 30 to 60 minutes before treatment
- Multiplace chambers that feel like sitting in a room rather than lying in a tube
- Communication systems that allow continuous contact with technicians
- Gradual pressure exposure protocols that build tolerance over 2 to 3 introductory sessions
How to Get Evaluated: Your Step-by-Step Path to Treatment
Knowing you might be a candidate is different from actually getting evaluated and starting treatment. Here's the practical roadmap.
Step 1: Get a Referral (or Self-Refer)
For FDA-approved conditions with insurance coverage, you typically need a referral from your treating physician — your wound care specialist, oncologist, or primary care doctor. They'll document the condition, prior treatments, and medical necessity.
For off-label uses, most hyperbaric centers accept self-referrals. You don't need your PCP's permission to pursue HBOT for TBI or long COVID, but having their support helps coordinate care and may be important if complications arise.
Step 2: Choose a Qualified Center
Not all HBOT facilities are equal. Look for:
- Physician oversight: A board-certified hyperbaric medicine physician should be directing treatment. The UHMS offers board certification in undersea and hyperbaric medicine.
- Accreditation: UHMS facility accreditation is the gold standard. It means the center meets safety standards for equipment maintenance, staff training, and emergency protocols.
- Chamber type: Clinical-grade hard-shell chambers pressurized to 2.0 ATA or higher for approved indications. Mild hyperbaric (1.3 ATA soft chambers) may be appropriate for some off-label uses but aren't suitable for FDA-cleared indications.
- Emergency capabilities: The center should have emergency protocols for oxygen toxicity seizures, cardiac events, and barotrauma.
Top-tier facilities like Penn Medicine maintain UHMS accreditation with full physician staffing. MD Hyperbaric Chicago offers both monoplace and multiplace chambers to accommodate different patient needs. UI Health provides comprehensive wound care integration alongside their hyperbaric program.
Step 3: Complete the Pre-Treatment Evaluation
As detailed in the section above, this includes medical history review, physical examination, and potentially TcPO2 testing for wound patients. Budget 60 to 90 minutes for the initial evaluation.
Step 4: Insurance Verification and Authorization
For approved indications, the center's insurance coordinator will submit pre-authorization. Typical turnaround is 5 to 10 business days. Medicare covers most approved indications with standard copay/coinsurance. Private insurance coverage varies — Aetna, UnitedHealthcare, and Blue Cross Blue Shield all cover UHMS-approved indications with prior authorization and clinical documentation.
For off-label uses, expect to pay out of pocket. Many centers offer package pricing — 20 sessions at a reduced per-session rate, for example. Typical costs range from $150 to $400 per session depending on geographic location, chamber type, and facility.
Step 5: Begin Treatment
Most protocols involve 5 sessions per week (Monday through Friday) for 4 to 8 weeks. Each session lasts 90 to 120 minutes, including compression and decompression time. Diabetic wound patients typically receive 20 to 40 sessions. TBI protocols often run 40 to 60 sessions. Radiation injury treatment may extend to 40 to 60 sessions depending on severity and location.
Treatment progress is monitored throughout — wound measurements, neurological assessments, or imaging as appropriate. Remember: Medicare requires documented improvement within every 30-day window, or coverage stops.
Frequently Asked Questions
Can I get HBOT if I have diabetes but my wound isn't Wagner grade III? Technically, Medicare's coverage determination specifies Wagner grade III or higher. However, some private insurers cover grade II wounds with evidence of non-healing. For grades I and II, you can pursue HBOT out of pocket, though the evidence for HBOT benefit is strongest in more severe wounds. Discuss with your wound care team whether the severity justifies the intervention.
Does HBOT work for healthy people looking for wellness benefits? HBOT won't harm a healthy person (assuming no contraindications), but the evidence for benefits in healthy individuals is limited. The telomere/senescence study was conducted on adults over 64 using a specific 60-session protocol. Casual wellness use at 1.3 ATA in soft chambers delivers significantly less oxygen than clinical protocols and has minimal published evidence supporting broad health claims.
How do I know if my HBOT center is legitimate? Check for UHMS facility accreditation (searchable on uhms.org), verify physician credentials in hyperbaric medicine, ask about chamber inspection and maintenance records, and confirm they have emergency protocols. Any center that guarantees results, refuses to discuss contraindications, or offers treatment without a physician evaluation should be avoided.
Can I get HBOT if I've had ear surgery or have hearing problems? Previous ear surgery, particularly tympanoplasty or mastoidectomy, requires ENT clearance before HBOT. Patients with tympanic membrane perforations may actually tolerate pressure changes better (no equalization needed), but the perforation can allow water or chamber atmosphere into the middle ear. Custom ear molds or protective measures may be needed. Hearing loss alone is not a contraindication.
What if I can't tolerate a full 90-minute session? Centers routinely accommodate patients who need shorter initial sessions. A common approach is starting with 30 to 45-minute sessions at lower pressure (1.5 ATA) and gradually increasing to the full protocol over 3 to 5 introductory sessions. Some patients require permanent protocol modifications — shorter sessions at slightly lower pressure — which can still be therapeutically effective.
Related Reading
- The Complete Guide to Hyperbaric Oxygen Therapy [2026]
- HBOT Side Effects and Risks: What You Need to Know [2026]
- HBOT for Beginners: What to Know Before Your First Visit
-- The HBOT Finder Team